Bahrain is offering Pfizer-BioNTech doses to certain high-risk vaccinated individuals who took the Chinese vaccine. The decision sends a signal to the world that two doses of the Sinopharm vaccine aren't enough. The Sinopharm vaccine was developed by the Beijing Institute of Biological Products. The decision comes just weeks after the World Health Organization granted Sinopharm emergency use listing.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting